Big Pharma Needs New Drugs. China Has Them
American pharma giants are increasingly turning to Chinese labs to discover, test and develop cutting-edge drugs. On the Big Take Asia podcast, Bloomberg’s Amber Tong and Robert Langreth join Oanh Ha ...
20 Sep 17min
Japan Hikes Rates, Reshaping Carry Trade
It’s been a big week for central banks around the world. Yet among the flurry of rate decisions, the Bank of Japan’s move stands out. After decades of near-zero interest rates, policymakers are bettin...
18 Sep 16min
Most Americans Say They’re Working Class. Are They?
The “working class” in America used to conjure a vivid image: factory workers, blue-collar jobs and a political coalition born out of the Industrial Revolution. But as Republicans and Democrats try to...
17 Sep 18min
Why the Federal Reserve Raised Interest Rates
The Federal Reserve raised interest rates by 25 basis points today and indicated another hike could come later this year. Chair Kevin Warsh had telegraphed the move, putting him on a collision course ...
16 Sep 17min
Can the AI Industry Slow Down?
AI executives across the industry, led by Anthropic CEO Dario Amodei, called for a coordinated slow down in AI development over the weekend. The move followed a viral post on X from a former Anthropic...
15 Sep 16min
Why Canada Is Cozying Up to Europe
In the midst of a trade war with the US, Canadian Prime Minister Mark Carney is on a charm offensive. On today’s Big Take podcast, Bloomberg’s Derek Decloet and host David Gura break down how Canada i...
14 Sep 18min
LIV Golf’s $5 Billion Path to Bankruptcy
LIV Golf split the professional circuit early this decade with its flashy tournaments and payouts that outstripped what golfers were earning on PGA tours. Now, after five years — and more than $5 bill...
13 Sep 16min
